期刊文献+

快速膜乳化法制备载紫杉醇聚乳酸类微球 被引量:18

Preparation of Microspheres of Paclitaxel-loaded PLA, PLGA and PELA by Premix Membrane Emulsification
在线阅读 下载PDF
导出
摘要 采用快速膜乳化法、均质乳化法和超声法制备了聚乳酸(PLA)空白微球,比较了3种方法所制微球的均一性.采用均质乳化法和超声法制备的PLA微球平均粒径分别为1.022和0.987μm,多分散系数分别为0.133和0.145,而快速膜乳化法制备的PLA微球平均粒径为0.906μm,多分散系数为0.005.在此基础上,采用快速膜乳化法制备了聚乳酸、聚(乳酸-羟基乙酸)共聚物(PLGA)和聚(乳酸-聚乙二醇)二嵌段共聚物(PELA)载紫杉醇微球,平均粒径分别为0.906,0.987和1.015μm,多分散系数均为0.005,载药率分别为3.89%,4.93%和3.18%,包埋率分别为63.2%,71.6%和51.3%,在磷酸盐缓冲液中释放60d后,PLGA微球的药物释放率为83.87%,PLA微球为50.25%,PELA微球为41.27%. Poly(lactic acid) (PLA) microspheres were prepared by premix membrane emulsification and compared with the results by homogenization and ultrasonification. The mean diameters of PLA microspheres prepared by homogenization and ultrasonification were 1.022 and 0.987 μm, and the corresponding polydispersities 0.133, 0.145, respectively, while the mean diameter of PLA microspheres by premix membrane emulsification was 0.906 μm and the polydispersity 0.005. Furthermore, the microspheres of paclitaxel (PTX) loaded PLA, PLGA [poly(lactic-co-glycolic acid)], PELA [poly(ethylene glycol-co-lactide acid)] with uniform size were prepared by premix membrane emulsification, and their encapsulation efficiency and cumulative release profiles in vitro were studied. The mean diameters of PTX-loaded PLA, PLGA and PELA microspheres were 0.906, 0.987 and 1.015 μm with the same polydispersity of 0.005. The corresponding drug loading efficiencies and encapsulation efficiencies were 3.89%, 4.93%, 3.18% and 63.2%, 71.6%, 51.3%, respectively. The cumulative release rates of PLA, PLGA, and PELA microspheres in vitro for 60 d were 83.87%, 50.25% and 41.27%.
出处 《过程工程学报》 CAS CSCD 北大核心 2010年第3期568-575,共8页 The Chinese Journal of Process Engineering
关键词 快速膜乳化 聚乳酸类微球 均一性 载药率 体外释放 premix membrane emulsification microspheres uniformity loading efficiency drug release in vitro
作者简介 作者简介:曾烨婧(1985-),女,江西省吉安市人,硕士研究生,制药工程专业; 王连艳,通讯联系人,Tel:010-62557095,E-mail:wanglianyan@home.ipe.ac.cn.
  • 相关文献

参考文献18

  • 1王思铭.紫杉醇长效注射缓释微球的体内外评价[J].长春中医药大学学报,2007,23(3):15-16. 被引量:3
  • 2Safavy A,Bonner J A,Waksal H W,et al.Synthesis and Biological Evaluation of Paclitaxel-C225 Conjugate as Model for Target Drug Delivery[J].Bioconjugate Chem,2003,14(2):302-310.
  • 3王海燕,李运曼,刘国卿.紫杉醇抗癌机制研究进展[J].药学进展,1999,23(4):209-214. 被引量:15
  • 4金涛,李铁晶,吴桐,王颖,周东坡.紫杉醇抗肿瘤机理与毒副作用[J].东北农业大学学报,2005,36(6):816-819. 被引量:16
  • 5Dhanikula A B,Panchagnula R.Localized Paclitaxel Delivery[J].Int.J.Pharm.,1999,183(2):85-100.
  • 6Adams J D,Flora K P,Goldspier B R,et al.Taxol:A History of Pharmceutical Development and Current Pharmceutical Concerns[J].J.Natl.Cancer Inst.Monogrphs,1993,(15):141-147.
  • 7Allwood M,Maritin H.The Extraction of Diethylhexyl Phthalate (DEHP) from Polyvinyl Chloride Components of Intravenous Infusion Containers and Administration[J].Int.J.Pharm.,1996,127(1):57-61.
  • 8马培奇.新颖蛋白结合微粒药物紫杉醇新制剂Abraxane在美首次获准上市[J].中国医药技术与市场,2005,5(6):17-19. 被引量:1
  • 9Milan F M.Method for the Treatment of Solid Tumors by Albumin Microparticles Incorporating Paclitaxel[P].US Pat.:US6652884B2,2003-11-25.
  • 10Ruan G,Feng S S.Preparation and Characterization of Poly(lactic acid)-Poly(ethylene glycol)-Poly(lactic acid) (PLA-PEG-PLA) Microspheres for Controlled Release of Paclitaxel[J].Biomaterials,2003,24(27):5037-5044.

二级参考文献79

共引文献65

同被引文献277

引证文献18

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部